Taysha Gene Therapies financial statements

타이샤 진 테라피스NASDAQ:TSHA · Nasdaq · Healthcare · sector #17
$4.39-2.23%
2026-10-06 close

Taysha Gene Therapies's published financial data is dated 2026-10-04. 2024 revenue was $8M. 2024 operating profit was −$91M.

Reported results

Taysha Gene Therapies notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q